Adco Ropivacaine Injection

Indication

Local anesthesia for surgical procedures and pain management.

Dosage (summary)

Administered as an infusion; typical dosage varies based on the procedure and patient factors, generally starting at 0.2% to 0.75% concentration.

Onset of Action / Duration

Onset of action is typically within 20 minutes, with a duration of action lasting up to 8 hours depending on the dose and administration method.

Special Populations

• Elderly patients
• Patients with hepatic impairment
• Patients with renal impairment

Pregnancy & Breastfeeding

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution is advised during lactation as Ropivacaine may be excreted in breast milk.

Key Drug Interactions

• Other local anesthetics may increase the risk of systemic toxicity.
• Caution with anticoagulants due to increased bleeding risk at injection sites.

Contraindications

• Hypersensitivity to Ropivacaine or other amide local anesthetics.
• Severe liver disease.
• Infection at the injection site.

Common side effects

• Hypotension
• Bradycardia
• Nausea
• Dizziness
• Neurological symptoms (e.g., seizures, paresthesia)

Counselling Points

• Inform patients about the potential for temporary numbness and weakness following administration.
• Advise patients to avoid activities requiring full alertness until the effects of the medication have worn off.
• Discuss the signs of potential adverse reactions, such as difficulty breathing or severe allergic reactions.